Tomasz Litwin Selected Research

Copper

9/2022	Effect of homeostatic iron regulator protein gene mutation on Wilson's disease clinical manifestation: original data and literature review.
9/2022	Liver injury in Wilson's disease: An immunohistochemical study.
7/2022	Brain magnetic resonance imaging and severity of neurological disease in Wilson's disease - the neuroradiological correlations.
6/2022	Sleep disturbances in newly diagnosed treatment-naïve patients with Wilson's disease.
5/2022	Antioxidant Capacity Is Decreased in Wilson's Disease and Correlates to Liver Function.
4/2022	Liver transplantation as a treatment for Wilson's disease with neurological presentation: a systematic literature review.
2/2022	Wilson's disease- management and long term outcomes.
1/2021	Iron metabolism is disturbed and anti-copper treatment improves but does not normalize iron metabolism in Wilson's disease.
12/2020	Difference in iron metabolism may partly explain sex-related variability in the manifestation of Wilson's disease.
11/2020	mtDNA depletion-like syndrome in Wilson disease.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tomasz Litwin Research Topics

Disease

54	Hepatolenticular Degeneration (Wilson's Disease) 09/2022 - 04/2008
10	Inborn Genetic Diseases (Disease, Hereditary) 07/2022 - 03/2013
5	Brain Injuries (Brain Injury) 02/2022 - 04/2008
5	Neurologic Manifestations (Neurological Manifestations) 11/2019 - 08/2015
3	Disease Progression 01/2018 - 09/2013
2	Atrophy 11/2020 - 10/2019
2	Liver Diseases (Liver Disease) 04/2019 - 01/2019
2	Fibrosis (Cirrhosis) 01/2019 - 03/2015
2	Liver Failure 07/2018 - 03/2015
2	Multiple Sclerosis 01/2018 - 03/2017
2	Parkinson Disease (Parkinson's Disease) 01/2015 - 10/2004
2	Stroke (Strokes) 01/2012 - 01/2008
1	Acute Liver Failure (Fulminant Hepatic Failure) 02/2022
1	Nervous System Trauma 01/2022
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 11/2020
1	Neurodegeneration with brain iron accumulation (NBIA) 11/2020
1	Dementia (Dementias) 11/2020
1	Infections 01/2020
1	Chronic Disease (Chronic Diseases) 11/2019
1	Cataract (Cataracts) 04/2019
1	Gliosis 04/2019
1	Demyelinating Diseases (Demyelinating Disease) 04/2019
1	Cognitive Dysfunction 01/2019
1	Relapsing-Remitting Multiple Sclerosis 01/2018
1	Brain Diseases (Brain Disorder) 03/2015
1	Inflammation (Inflammations) 01/2015
1	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2013
1	Ischemic Stroke 01/2008
1	Seizures (Absence Seizure) 02/2007

Drug/Important Bio-Agent (IBA)

46	CopperIBA 09/2022 - 04/2008
8	IronIBA 09/2022 - 05/2012
5	Copper Transport ProteinsIBA 05/2022 - 10/2018
5	Penicillamine (Cuprimine)FDA Link 01/2021 - 02/2014
3	Proteins (Proteins, Gene)FDA Link 09/2022 - 01/2015
3	AntioxidantsIBA 05/2022 - 02/2014
3	ZincIBA 01/2017 - 01/2014
2	Zinc Sulfate FDA Link 01/2020 - 08/2015
2	Ceruloplasmin (Ferroxidase)IBA 10/2019 - 01/2015
2	Fingolimod Hydrochloride (FTY720)FDA Link 01/2018 - 03/2017
2	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2012 - 01/2008
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	CollagenIBA 01/2021
1	Mitochondrial DNA (mtDNA)IBA 11/2020
1	UreaseIBA 01/2020
1	Phenylalanine (L-Phenylalanine)FDA Link 11/2019
1	Tyrosine (L-Tyrosine)FDA Link 11/2019
1	Methionine (L-Methionine)FDA Link 11/2019
1	Choline (Choline Chloride)IBA 11/2019
1	Aromatic Amino Acids (Aromatic Amino Acid)IBA 11/2019
1	Histidine (L-Histidine)FDA Link 11/2019
1	Pharmaceutical PreparationsIBA 11/2019
1	Polycomb Repressive Complex 1IBA 01/2019
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2019
1	hydrogen sulfite (bisulfite)IBA 01/2019
1	ThioredoxinsIBA 11/2018
1	Natalizumab (Tysabri)FDA Link 01/2018
1	siponimodIBA 01/2018
1	SaltsIBA 01/2017
1	Chelating AgentsIBA 01/2017
1	Retinaldehyde (Retinal)IBA 04/2016
1	Dopamine AntagonistsIBA 08/2015
1	ManganeseIBA 02/2015
1	Familial apoceruloplasmin deficiencyIBA 02/2015
1	MetalsIBA 02/2015
1	MetalloproteinsIBA 01/2015
1	SynucleinsIBA 01/2015
1	TeaIBA 01/2015
1	Adenosine Triphosphatases (ATPase)IBA 01/2014
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 09/2013
1	Antihypertensive Agents (Antihypertensives)IBA 01/2012
1	4- Acetamido- 4'- isothiocyanatostilbene- 2,2'- disulfonic Acid (SITS)IBA 01/2008
1	Blood Glucose (Blood Sugar)IBA 02/2007
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2004

Therapy/Procedure

3	Liver Transplantation 04/2022 - 04/2008
3	Therapeutics 01/2020 - 01/2014
1	Aftercare (After-Treatment) 01/2017
1	Time-to-Treatment 01/2012
1	Thrombolytic Therapy 01/2008